Idarubicin-bromelain combination sensitizes cancer cells to conventional chemotherapy

OBJECTIVE(S): The primary cytotoxic effects of anticancer drugs like idarubicin, a chemotherapeutic agent, are not limited to neoplastic cells; they also produce similar effects in normal cells. In this study, we hypothesized that the combination of idarubicin-bromelain could make cancer cells more...

Descripción completa

Detalles Bibliográficos
Autores principales: Taşkın, Abdullah, Tarakçıoğlu, Mehmet, Ulusal, Hasan, Örkmez, Mustafa, Taysı, Seyithan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885387/
https://www.ncbi.nlm.nih.gov/pubmed/31998459
http://dx.doi.org/10.22038/ijbms.2019.37884.9003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885387/
https://www.ncbi.nlm.nih.gov/pubmed/31998459
http://dx.doi.org/10.22038/ijbms.2019.37884.9003

Ejemplares similares